Sanofi-aventis.fr - Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USA

Provided by Alexa ranking, sanofi-aventis.fr has ranked N/A in N/A and 2,638,744 on the world. sanofi-aventis.fr reaches roughly 1,178 users per day and delivers about 35,333 users each month. The domain sanofi-aventis.fr uses a Commercial suffix and it's server(s) are located in N/A with the IP number 54.247.151.159 and it is a .fr domain.

WebFeb 23, 2024 · Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments.

List of domain same IP 54.247.151.159

Search Results related to sanofi-aventis.fr on Search Engine

Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USA
sanofi.us

https://www.sanofi.us/en

WebFeb 23, 2024 · Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments.

DA: 89 PA: 76 MOZ Rank: 91

Sanofi: global healthcare and pharmaceutical company
sanofi.com

https://www.sanofi.com/en

WebMar 21, 2024 · About Us. Who We Are. We are an innovative global healthcare company. Read more. Our Science. We turn the impossible into possible. Read more. Your Health. We chase the miracles of science to improve people’s lives. Read more. Our Commitment. We have reimagined a bold sustainable approach. Read more. Our Pipeline. 6.

DA: 31 PA: 14 MOZ Rank: 44

Our Company, a global pharmaceutical company (medicines ... - Sanofi
sanofi.com

https://www.sanofi.com/en/our-company

WebWe want to build a healthier, more resilient world. We turn the impossible into the possible by discovering, developing, and delivering medicines and vaccines for millions of people around the world.

DA: 98 PA: 30 MOZ Rank: 61

Sanofi - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Sanofi

WebSanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several …

DA: 95 PA: 73 MOZ Rank: 51

Our Products and Resources | Sanofi USA
sanofi.us

https://www.sanofi.us/en/your-health/products

WebProducts and Resources. This information is intended for U.S. residents. Sanofi is a diversified global healthcare leader, focused on developing products that meet the health needs of people. We have extensive lines of prescription medicines and vaccines, as well as consumer health products.

DA: 50 PA: 45 MOZ Rank: 82

Contact Us - Information and Resources | Sanofi USA
sanofi.us

https://www.sanofi.us/en/contact-us

WebSanofi US endeavors to make our Career Center accessible to any and all users. If you are experiencing difficulty and need assistance applying online, please call 1-866-SANOFI2 or click here.

DA: 6 PA: 8 MOZ Rank: 27

Sanofi-Aventis | Pharmaceuticals, Vaccines, Biotechnology
britannica.com

https://www.britannica.com/money/Sanofi-Aventis

WebMar 29, 2024 · Sanofi-Aventis, French pharmaceutical company founded in 2004 through the merger of Sanofi-Synthélabo SA and a much larger French firm, Aventis. Primarily focused on the development and sale of prescription medications, Sanofi-Aventis is one of Europe’s largest pharmaceutical firms.

DA: 44 PA: 77 MOZ Rank: 3

Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary …
yahoo.com

https://finance.yahoo.com/news/press-release-rilzabrutinib-luna-3-050000137.html

Web1 day ago · Sanofi - Aventis Groupe. Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia. Pivotal data from the first phase 3 study of a BTKi in immune thrombocytopenia (ITP ...

DA: 57 PA: 38 MOZ Rank: 61

Press Release: Rilzabrutinib LUNA 3 phase 3 study met
globenewswire.com

https://www.globenewswire.com/news-release/2024/04/23/2867327/0/en/Press-Release-Rilzabrutinib-LUNA-3-phase-3-study-met-primary-endpoint-in-immune-thrombocytopenia.html

Web1 day ago · LUNA 3 (NCT04562766) is a randomized, multicenter, phase 3 study evaluating the efficacy and safety of rilzabrutinib vs placebo in adult and adolescent patients with persistent or chronic ITP ...

DA: 46 PA: 52 MOZ Rank: 58

Press Release: Sanofi Enters Next Chapter of Play to Win Strategy
yahoo.com

https://finance.yahoo.com/news/press-release-sanofi-enters-next-053000963.html

WebFri, Oct 27, 2023 10 min read. In this article: SAN.PA. SNYNF. Sanofi - Aventis Groupe. Sanofi Enters Next Chapter of Play to Win Strategy. Increases investments in its pipeline to fully...

DA: 92 PA: 10 MOZ Rank: 95

Alexa Rank

GLOBAL RANK

2,638,744

Alexa Reach

0.0000519918

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

1,178

Monthly Unique Visitors

35,333

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

7,558

Indonesia

5,911

Taiwan

1,922

United Kingdom

1,707

Brazil

1,544

Nigeria

1,350

Egypt

1,134

Hong Kong

1,071

Canada

1,071

Australia

933

Philippines

668

India

650

Malaysia

640

Spain

530

Germany

516

Mexico

495

France

466

Italy

431

Turkey

396

Iraq

360

Thailand

353

Netherlands

339

Israel

336

Cambodia

279

Algeria

216

Ireland

194

Romania

187

Jordan

173

Poland

166

Ghana

159

Argentina

152

South Africa

138

Belgium

124

Czechia

113

Ukraine

106

Japan

106

Morocco

102

South Korea

Lebanon

Saudi Arabia

Austria

Hungary

Sweden

Singapore

Pakistan

Bangladesh

Denmark

Greece

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa Statistics Graph for sanofi-aventis.fr

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DNS Record

Host	Type	Class	TTL	Extra
sanofi-aventis.fr	A	IN	900	Ip: 54.247.151.159
sanofi-aventis.fr	NS	IN	900	Target: ns1.sanofi-synthelabo.com
sanofi-aventis.fr	NS	IN	900	Target: ns2.sanofi-synthelabo.com
sanofi-aventis.fr	NS	IN	900	Target: ns3.sanofi-synthelabo.com
sanofi-aventis.fr	NS	IN	900	Target: ns4.sanofi-synthelabo.com
sanofi-aventis.fr	SOA	IN	900	Mname: ns1.sanofi-synthelabo.com Rname: gtly-domtech.sanofi.com Serial: 2016030779 Refresh: 28800 Retry: 14400 Expire: 3600000 Minimum-ttl: 900
sanofi-aventis.fr	MX	IN	900	Pri: 10 Target: mailera.sanofi.com
sanofi-aventis.fr	MX	IN	900	Pri: 10 Target: mailerb.sanofi.com

Hosting and Whois Zone

IP	54.247.151.159
Domain infomation	%% %% This is the AFNIC Whois server. %% %% complete date format: YYYY-MM-DDThh:mm:ssZ %% %% Rights restricted by copyright. %% See https://www.afnic.fr/en/domain-names-and-support/everything-there-is-to-know-about-domain-names/find-a-domain-name-or-a-holder-using-whois/ %% %% domain: sanofi-aventis.fr status: ACTIVE eppstatus: active hold: NO holder-c: DN2220-FRNIC admin-c: TLD47-FRNIC tech-c: DM10498-FRNIC registrar: CSC CORPORATE DOMAINS INC. Expiry Date: 2024-10-16T17:31:02Z created: 2006-12-18T16:56:57Z last-update: 2023-10-17T05:18:47.623566Z source: FRNIC nserver: ns1.sanofi-synthelabo.com nserver: ns2.sanofi-synthelabo.com nserver: ns3.sanofi-synthelabo.com nserver: ns4.sanofi-synthelabo.com source: FRNIC registrar: CSC CORPORATE DOMAINS INC. address: 251 Little Falls Drive address: DE 19808 WILMINGTON country: US phone: +1.3026365400 fax-no: +1.3026365454 e-mail: [email protected] website: https://www.cscdigitalbrand.services anonymous: No registered: 2006-10-16T00:00:00Z source: FRNIC nic-hdl: TLD47-FRNIC type: ORGANIZATION contact: Trademark Legal Department address: Sanofi address: 20, avenue Raymond Aron address: 92160 Antony Fr country: FR phone: +33.141245875 fax-no: +33.141241502 e-mail: [email protected] registrar: CSC CORPORATE DOMAINS INC. anonymous: NO obsoleted: NO eppstatus: associated eppstatus: active eligstatus: ok eligsource: REGISTRAR eligdate: 2013-10-14T00:00:00Z reachstatus: ok reachmedia: email reachsource: REGISTRAR reachdate: 2013-10-14T00:00:00Z source: FRNIC nic-hdl: DM10498-FRNIC type: ORGANIZATION contact: DNS Master address: Sanofi address: 1, rue Victor Basch address: 91349 Massy Fr country: FR phone: +33.141245838 fax-no: +33.141247016 e-mail: [email protected] registrar: CSC CORPORATE DOMAINS INC. anonymous: NO obsoleted: NO eppstatus: associated eppstatus: active eligstatus: ok eligsource: REGISTRAR eligdate: 2013-10-14T00:00:00Z reachstatus: ok reachmedia: email reachsource: REGISTRAR reachdate: 2013-10-14T00:00:00Z source: FRNIC nic-hdl: DN2220-FRNIC type: ORGANIZATION contact: Domain Names address: Sanofi address: 54, rue la Boetie address: 75008 Paris Fr country: FR phone: +33.141245875 fax-no: +33.141241502 e-mail: [email protected] registrar: CSC CORPORATE DOMAINS INC. anonymous: NO obsoleted: NO eppstatus: associated eppstatus: active eligstatus: ok eligsource: REGISTRAR eligdate: 2013-10-14T00:00:00Z reachstatus: not identified source: FRNIC >>> Last update of WHOIS database: 2024-04-24T14:56:31.093879Z <<<